Moolec Science (MLEC) Retained Earnings (2022 - 2025)
Moolec Science's (MLEC) quarterly Retained Earnings came in at -$44.6 million in Q4 2025, up 36.58% year-on-year from -$32.6 million in Q4 2024, and up 60.13% quarter-over-quarter from -$111.8 million in Q2 2025.
Moolec Science (MLEC) Retained Earnings (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Retained Earnings across 4 years of filings, most recently posting -$44.6 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at -$44.6 million, up 36.58% year-over-year; the trailing twelve-month figure through Dec 2025 was -$44.6 million (up 36.58% YoY), and the FY2025 annual result was -$111.8 million, down 9882.57% from the prior year.
- Retained Earnings came in at -$44.6 million for Q4 2025 at Moolec Science, up from -$111.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.1 million in Q2 2024 to a low of -$111.8 million in Q2 2025.
- The 4-year median for Retained Earnings is -$60.2 million (2023), against an average of -$54.5 million.
- Across the five-year window, Retained Earnings jumped 101.95% in 2024 and slumped 9882.57% in 2025, its largest moves.
- Moolec Science's Retained Earnings stood at -$55.5 million in 2022, then declined by 11.67% to -$62.0 million in 2023, then dropped by 13.36% to -$70.3 million in 2024, then surged by 36.58% to -$44.6 million in 2025.
- The last three Retained Earnings figures came in at -$44.6 million (Q4 2025), -$111.8 million (Q2 2025), and -$70.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -44.57 Mn |
| Jun 30, 2025 | -111.79 Mn |
| Dec 31, 2024 | -70.28 Mn |
| Sep 30, 2024 | -67.85 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | -63.40 Mn |
| Dec 31, 2023 | -62.00 Mn |
| Sep 30, 2023 | -60.21 Mn |
| Jun 30, 2023 | -58.62 Mn |
| Dec 31, 2022 | -55.52 Mn |
| Jun 30, 2022 | -6.83 Mn |